Various forms of cancer have been linked to the carcinogenic activities of microorganisms [1] [2] [3] . The virulent gene island polyketide synthase ( pks) produces the secondary metabolite colibactin, a genotoxic molecule(s) causing double-stranded DNA breaks 4 and enhanced colorectal cancer development 5, 6 . Colibactin biosynthesis involves a prodrug resistance strategy where an N-terminal prodrug scaffold (precolibactin) is assembled, transported into the periplasm and cleaved to release the mature product [7] [8] [9] [10] . Here, we show that ClbM, a multidrug and toxic compound extrusion (MATE) transporter, is a key component involved in colibactin activity and transport. Disruption of clbM attenuated pks+ E. coli-induced DNA damage in vitro and significantly decreased the DNA damage response in gnotobiotic Il10 −/− mice. Colonization experiments performed in mice or zebrafish animal models indicate that clbM is not implicated in E. coli niche establishment. The X-ray structure of ClbM shows a structural motif common to the recently described MATE family. The 12-transmembrane ClbM is characterized as a cationcoupled antiporter, and residues important to the cation-binding site are identified. Our data identify ClbM as a precolibactin transporter and provide the first structure of a MATE transporter with a defined and specific biological function.
Various forms of cancer have been linked to the carcinogenic activities of microorganisms [1] [2] [3] . The virulent gene island polyketide synthase ( pks) produces the secondary metabolite colibactin, a genotoxic molecule(s) causing double-stranded DNA breaks 4 and enhanced colorectal cancer development 5, 6 . Colibactin biosynthesis involves a prodrug resistance strategy where an N-terminal prodrug scaffold (precolibactin) is assembled, transported into the periplasm and cleaved to release the mature product [7] [8] [9] [10] . Here, we show that ClbM, a multidrug and toxic compound extrusion (MATE) transporter, is a key component involved in colibactin activity and transport. Disruption of clbM attenuated pks+ E. coli-induced DNA damage in vitro and significantly decreased the DNA damage response in gnotobiotic Il10 −/− mice. Colonization experiments performed in mice or zebrafish animal models indicate that clbM is not implicated in E. coli niche establishment. The X-ray structure of ClbM shows a structural motif common to the recently described MATE family. The 12-transmembrane ClbM is characterized as a cationcoupled antiporter, and residues important to the cation-binding site are identified. Our data identify ClbM as a precolibactin transporter and provide the first structure of a MATE transporter with a defined and specific biological function.
Microbial dysbiosis has been associated with the development of colorectal cancer (CRC) in both human and mouse models, suggesting that bacterial populations represent an important component of intestinal pathology 1, 2 . Specific microbial genes are directly implicated in tumorigenesis, supporting the concept that microbial activities influence CRC 3 . The adherent invasive Escherichia coli strain NC101 promotes CRC development in azoxymethane-treated Il10 −/− mice through the action of colibactin, a natural product(s) derived from the genotoxic hybrid polyketide synthase/nonribosomal peptide synthetase ( pks) gene island 6 . The pks island has been found in a higher prevalence in mucosa-adherent E. coli isolated from the intestine of CRC patients compared to non-CRC controls, suggesting a potential link between pks carrier isolates and tumorigenesis 6, 11 . The ability of pks+ E. coli strains to promote tumorigenesis is linked to the property of colibactin to induce double-stranded DNA breaks and cell senescence in various cell types, including intestinal epithelial cells [4] [5] [6] . The secondary metabolite colibactin has yet to be fully defined chemically, although several small molecules, including a proposed 'warhead', have recently been linked to the biosynthetic pathway 9, 10, [12] [13] [14] [15] [16] [17] . The prodrug scaffold N-myristoyl-D-asparagine (1) has been identified as a periplasmic cleavage product 9, 10 . A transcriptomic analysis of E. coli NC101 gene expression using RNA-seq showed that the pks island was a highly responsive operon during the development of colitisassociated CRC in Il10 −/− mice 5 . Interestingly, clbM was among the five pks genes most responsive to inflammation/cancer 5 . ClbM is homologous to the MATE membrane-embedded transporters, a family largely believed to play a role in cell detoxification, evidenced by their general transport activity against antibiotics and cationic molecules of studied examples [18] [19] [20] [21] . To assess the transport capacity of ClbM, we measured minimal inhibitory concentrations (MICs) of a panel of antibiotics and toxic compounds in E. coli KAM32 transformed with pk184 (clbM) or the empty vector. E. coli susceptibility to antibiotics and toxins was not improved by the presence of ClbM, suggesting a more specialized function for this transporter (Supplementary Table 1 ). Interestingly, overexpression of clbM in E. coli C43(DE3)ΔacrAB prevented accumulation of ethidium, a common indicator of MATE function ( Supplementary Fig. 1a ). AcrA and AcrB are components of the AcrAB-TolC transport system, which is capable of exporting a wide range of small molecules 22 . Additionally, ethidium transport was responsive to the concentration of extracellular Na + , suggesting that ClbM-mediated transport is cation-coupled ( Supplementary Fig. 1a) .
Because pks+ E. coli mediate a host genotoxic response in mammalian cells, we focused our attention on the relationship between ClbM and the DNA damage response. To evaluate the effect of ClbM on genotoxicity, we deleted the transporter (ΔclbM) in E. coli NC101, and also generated a control transporter mutant (ΔacrA) in order to determine the role of the AcrAB-TolC system in precolibactin transport. We infected IEC-6 cells with NC101, ΔclbM or ΔacrA (multiplicity of infection (MOI) = 30) for 4 h and examined the levels of phosphorylated histone H2AX (γH2AX), a surrogate marker for DNA damage 23 . Immunofluorescent staining analysis showed strong attenuation of γH2AX in ΔclbM-infected cells compared to NC101-infected cells (Fig. 1a) . We then used flow cytometry to quantitatively assess γH2AX induction and found that the DNA damage response was reduced by ∼70% in ΔclbM-infected cells compared to NC101-infected cells (Fig. 1b,c) . Consistent with the attenuated γH2AX induction, ΔclbM-infected cells showed decreased DNA damage, as demonstrated by a single-cell gel electrophoresis assay (comet assay) (Fig. 1d) . Similar results were observed using the colonic cell line HT29 ( Supplementary  Fig. 2 ). Decreased genotoxic activity was not due to impaired bacterial growth in vitro or bacterial attachment and invasion ( Supplementary  Fig. 3 ). Importantly, neither γH2AX induction nor DNA damage appeared to be affected in ΔacrA (Fig. 1a-d) . Together, these data suggest that ClbM is important for colibactin genotoxic activity. It is worth noting that the partial requirement of clbM for the genotoxic effect was not observed at high infectious dose (MOI = 100) ( Supplementary Fig. 4) , consistent with the previous report 4 .
ClbP, located in the bacterial inner membrane, generates 1 from precolibactin [7] [8] [9] [10] . Western blot analysis of fractionated E. coli C43(DE3) membranes expressing deca-histidine-tagged ClbM showed that the transporter was located at the inner membrane ( Supplementary  Fig. 5 ). If ClbM is implicated in precolibactin transport to the site of cleavage (ClbP), deletion of clbM should impair production of 1. Indeed, liquid chromatography-mass spectrometry (LC-MS) analysis of bacterial culture media extracts showed that 1 accumulation was significantly reduced in ΔclbM compared with NC101 and ΔacrA (Fig. 1e,f) . To further evaluate the transport capacity of ClbM, we measured 1 accumulation in E. coli MG1655 harbouring BAC-pks (MGpks+). Similar to the observation in NC101, disruption of clbM reduced the amount of 1 detected in MGpks+ (Supplementary Fig. 1b) . We then deleted clbH, a downstream NRPS gene involved in precolibactin assembly. Interestingly, accumulation of 1 was significantly reduced in the double mutant MGpks+ΔclbMΔclbH compared to MGpks+ΔclbH (Supplementary Fig. 1b ). These data suggest that ClbM can transport derailed biosynthetic products and ClbP cleavable metabolites (products of ΔclbH) as well as intact precolibactin.
To evaluate the role of clbM in vivo, we colonized germ-free Il10
−/− mice with NC101 or ΔclbM by oral gavage (10 8 c.f.u. per mouse) and examined bacterial colonization and the host DNA damage response. Although ΔclbM colonized to the same level as NC101 in the mouse gut 8 days post gavage (Fig. 2a) , γH2AX induction in the colonic epithelium of ΔclbM-colonized mice was significantly lower than in NC101-colonized mice (Fig. 2b) , suggesting the essential role of clbM for the NC101-induced genotoxic response in vivo. To visualize bacterial colonization in the gut, we took advantage of the transparent zebrafish larva model. NC101 or ΔclbM carrying ptdTomato were introduced statically into zebrafish (5 days post fertilization (d.p.f.)). A period of 24 h later, consistent with the observation in mice, NC101 and ΔclbM colonized equally well in zebrafish larvae ( Fig. 2c and Supplementary Videos 1 and 2). These observations suggest that clbM does not affect the capacity of NC101 to occupy a microbial niche but is important for the genotoxic effect.
The key role of clbM in pks-mediated genotoxicity led us to further probe the structure and mechanism of the transporter. ClbM was crystallized using lipid cubic phase crystallization 24 and the crystal structure was solved to 2.7 Å resolution (Supplementary Table 2 ). The overall topology consists of two pseudo-symmetrical lobes (N-lobe, TH1-TH6; C-lobe, TH7-TH12) and adopts a Vshaped conformation (Fig. 3a,b) . Based on the 'positive-inside' rule attributed to membrane protein topology, the central cavity in our crystal form is open to the periplasmic environment 25 . Only three unique homologue structures of the broad MATE family have so far been reported, including the cation transporter homologues NorM-VC and NorM-NG 26, 27 and proton transporters DinH and PfMATE 28, 29 . ClbM is topologically most similar to the PfMATE and NorM-VC/-NG transporters, yet shares low sequence identity with both ( Supplementary Fig. 6 ). Several lipid molecules from the crystallization medium are bound in the inter-lobe cleft, revealing a large binding pocket (Fig. 3b) . The binding pocket spans nearly 40 Å, noticeably larger than NorM and PfMATE ( Supplementary  Fig. 7 ), highlighting possible ClbM specificity for a postulated large 700-900 Da precolibactin molecule 15, 30 . To identify the cation-binding site, key to the antiport mechanism, the protein was crystallized with Rb + as the sole cation and the capability to induce γH2AX in vitro. For the estimation, a binary system was established by assuming 0% induction in control uninfected cells and 100% in NC101-infected cells, and data from four independent infection/flow cytometry experiments were averaged. *P < 0.0005 compared to NC101 and **P < 0.005 compared to control, one sample t-test. Error bars indicate s.d. d, ΔclbM induces less DNA damage (visualized by shorter comet tails) than NC101. Scale bars, 30 µm. e, LC-MS chromatogram of the SIM +343 m/z signal for compound 1 from one representative experiment. Three independent experiments were performed. f, Compound 1 accumulation is significantly reduced in ΔclbM. NS, not significant. *P < 0.01, one-way ANOVA followed by Newman-Keuls multiple comparison test. Error bars indicate s.d.
structure was solved to 3.3 Å. An isomorphous difference map revealed strong electron density on the C-terminal lobe, indicating a specifically bound Rb + (Fig. 3c) . No significant structural changes were observed between the native and Rb + -bound structure, consistent with the transporter in the drug-bound cation-bound state. The ClbM cation-binding site coordinates Rb + remarkably differently from NorM-VC/-NG, appearing to be bound solely through π-cation interactions with Y277(TH7) and F292(TH8), although D299(TH8) is within 7 Å. ClbM TH8 is kinked to bring both F292 and D299 in close proximity to the bound cation. Compared to ClbM, NorM-VC binds Rb + through Y367(TH10) oxygencation electrostatic interactions and F288(TH8) and F259(TH7) π-cation interactions; NorM-NG coordinates Cs + through a homologous Y294(TH8) and a substrate-bound-shifted E261(TH7). Comparing ClbM and NorM-VC/-NG structures revealed this unique site for ClbM cation binding ( Supplementary Fig. 8a-c) . Although unique residues are present in ClbM, an evolutionary conserved mechanism of cation binding is present, whereby π-cation interactions are used as primary sites of cation coordination. Furthermore, ClbM shares a conserved TH1 proline residue (P38), which has been demonstrated to be a critical switch point for drug release in the proton-coupled PfMATE 29 . TH1 may also be important for precolibactin export, where cation binding could trigger collapse of the drug-binding pocket. TH1 of ClbM maintains a straight conformation, similar to PfMATE(straight), further suggesting this structure of ClbM is in the drug-bound cation-bound state ( Supplementary Fig. 8d ).
Based on topological comparison between our structure, NorM-VC/-NG and PfMATE, a proposed mechanism for precolibactin transport by ClbM can be deduced. Our structure of ClbM is in the cation-bound/drug-bound state. Following this conformation, TH7 and TH8 can engage D299(TH7), which will collapse the drug-binding pocket, involving a TH1 conformational change around P38. Following drug release, a conformational change to the intracellular open state triggers cation release and cytoplasmic precolibactin binding, leaving ClbM in the drug-bound intracellular open state. A conformational shift will return ClbM to the cationfree drug-bound state, where cation binding will provide the starting point. Precolibactin release in the periplasmic space will serve as substrate for the peptidase ClbP, which will generate activated colibactin and the cleavage product 1 (Supplementary Fig. 9 ). Speculatively, extracellular release of both compounds may be accomplished through porin or resistance-nodulation-division-based export.
Here, we demonstrate that the transporter ClbM plays a major role in mediating colibactin-induced genotoxicity. ClbM is the first MATE transporter structurally characterized that has been related to a specific biological function, namely transporting precolibactin from the cytoplasm to the periplasmic space. ClbM is a functionally unique MATE transporter, yet shares a predicted evolutionary conserved mechanism with the cation-coupled NorM-family of MATE transporters. With increasing evidence that microorganisms, including pks+ E. coli strains, are involved in intestinal carcinogenesis, generating small-molecule inhibitors of MATE transporters could represent an attractive means with which to modulate tumorigenesis. Figure 2 | clbM is essential for NC101-induced genotoxic response in vivo. a, NC101 (n = 6) and ΔclbM (n = 8) colonize to similar levels in the mouse intestine. Eight days after gavage with NC101 or ΔclbM, mouse stools were plated on MacConkey agar to enumerate Enterobacteriaceae. No Enterobacteriaceae were cultured from control mice (n = 5). b, Immunohistochemistry analysis reveals significantly less γH2AX induction in the colon of mice colonized by ΔclbM than in those colonized by NC101. Scale bars, 50 μm. Right: each symbol represents data from one mouse. The mouse colonization experiment was repeated once. c, NC101 and ΔclbM (red fluorescence-labelled) colonize to similar levels in the 6 d.p.f. zebrafish intestine. Blue is DAPI counterstain. Each symbol represents data from a pool of three zebrafish guts. A total of 18 fish guts from three independent experiments were analysed for each group. NS, not significant; *P < 0.05 and **P < 0.01, two-tailed t-test. Error bars indicate s.d.
Methods
Ethics statement. All animal experiments were approved by the Institutional Animal Care and Use Committee of the University of Florida (protocols nos. 201308038 and 201308035).
Mutagenesis. NC101ΔclbM and NC101ΔacrA were generated using the λ RED recombination technique 31 . Briefly, the chloramphenicol resistant gene with flanking flippase recombination target (FRT) sites were polymerase chain reaction (PCR) amplified from the pKD3 plasmid using the primer sets clbMKO (forward, 5′-TGT TAA CGC AGG TGA CCT ATG CCA TCG CCG ATA TTT TTT GGC TGA GCC ACg tgt agg ctg gag ctg ctt c-3′; reverse, 5′-GGG AAA ACC AGC CCC ACA CCG GCA ATG ATG CCG CTG TTG GTG ACA TCA Ata tgg gaa tta gcc atg gtc c-3′) and acrAKO (forward, 5′-TTA ACT TTT GAC CAT TGA CCA ATT TGA AAT CGG ACA CTC GAG GTT TAC ATg tgt agg ctg gag ctg ctt c-3′; reverse, 5′-TCG GGC GAT CGA TAA AGA AAT TAG GCA TGT CTT AAC GGC TCC TGT TTA Aga tgg gaa tta gcc atg gtc c-3′). Each of the primers contains 50 nucleotides (indicated by capital letters) that are homologous to the upstream or downstream of the genetic regions to be deleted. The PCR products were gel-purified, digested with DpnI and transformed into E. coli NC101, which had previously been transformed with pKD46, which encodes the λ RED recombinase. Chloramphenicol-resistant clones were selected for successful genomic replacement of the first 177 nucleotides of clbM (to minimize the polar effect) or the entire acrA. pCP20, which encodes a thermally inducible flippase (FLP) recombinase, was then transformed into bacteria to remove the chloramphenicol-resistant cassette to generate NC101ΔclbM and NC101ΔacrA. Deletion of clbM (1-177 bp) and acrA on the E. coli NC101 chromosome was confirmed by PCR and sequencing.
E. coli MG1655 harbouring BAC-pks (MGpks+) was constructed as previously described 32 . MGpks+ΔclbM, MGpks+ΔclbH and MGpks+ΔclbHΔclbM were constructed by λ RED recombination using the primer set ΔclbM (forward, 5′-TCA TGG TGC CAC CTC CAT ATC CAA GTG TTG GGA GCG CAC CGC CTC CTG ATc ata tga ata tcc tcc tta g-3′; reverse, 5′-TCA TGG TGC CAC CTC CAT ATC CAA GTG TTG GGA GCG CAC CGC CTC CTG ATc ata tga ata tcc tcc tta g-3′) and ΔclbH (forward, 5′-ATG GA ACA GCA AGG GAT TAT GAG ACA GTT GCC TAC CGA CGA CCA AAC GAT gtg tag gct gga gct gct tc-3′; reverse, 5′-CGG TAT CCA CGG ATC TGC ACT TGG CGA TCT TGT CTG CCG AGA TAG AAC AAc ata tga ata tcc tcc tta g-3′) and pKD4 as a PCR template. Kanamycin cassettes in ΔclbM of MGpks+ΔclbM and MGpksΔclbHΔclbM and in ΔclbH of MGpks+ΔclbH were removed by flp recombination.
Bacterial growth evaluation. To monitor bacterial growth, 1 ml overnight cultures of NC101, NC101ΔclbM and NC101ΔacrA were diluted 1:100 with fresh LuriaBertani (LB) medium and shaken at 37°C. Cultures (1 ml) were collected at various time points and the optical density at 600 nm (OD 600 ) was obtained using NanoDrop2000 (Thermo Scientific). Growth curves were generated and analysed using GraphPad Prism 5.0.
In vitro infection. IEC-6 [IEC6] (ATCC CRL1592) or HT29 (ATCC HTB38) were obtained from ATCC. Both cell lines were tested to be negative of Mycoplasma using the MycoAlert Mycoplasma Detection Kit (LT07-218, Lonza). HT29 was authenticated using the GenePrint 10 System (B9510, Promega). IEC-6 was not authenticated.
Cells were plated at 5 × 10 4 per well in eight-chamber culture slides for γH2AX immunostaining, at 10 5 per well in 24-well tissue culture plates for bacterial attachment/invasion quantification (for infection of IEC-6 cells), or at 5 × 10 5 per well in six-well tissue culture plates for comet assay and γH2AX flow cytometry. Cells were allowed to adhere and then serum-starved overnight (16-18 h). Cells were infected with log phase NC101, NC101Δpks, NC101ΔclbM or NC101ΔacrA at the indicated MOI, determined by OD 600 , and incubated for 4 h at 37°C in a cell incubator under humidity and 5% CO 2 .
To assess bacterial attachment, cells were washed with sterile PBS three times and lysed in deionized H 2 O containing 1% Triton X-100 for 5 min in the incubator. Lysate was diluted in sterile PBS and plated on LB agar to enumerate adhering bacteria. To quantify invasion, infected cells were washed with PBS and incubated in media supplemented with gentamycin (200 μg ml ) for 1 h in the incubator. Cells were washed with PBS again and lysed as described above. Lysate was diluted in sterile PBS and plated on LB agar to enumerate bacterial invasion. Data were analysed using GraphPad Prism 5.0.
Examination of γH2AX in vitro. For γH2AX immunostaining, infected cells were washed with sterile PBS three times and incubated in gentamycin-supplemented medium overnight in the incubator. Cells were fixed and permeabilized using ice-cold methanol (10 min), washed with PBS to remove methanol, blocked with PBS containing 0.1% Tween 20 and 5% goat serum for 1 h at room temperature, and incubated with the Phospho-Histone H2AX (Ser139) (20E3) rabbit monoclonal antibody (9718, Cell Signalling) overnight at 4°C. Cells were washed with PBS and incubated in the secondary Alexa Fluor 488 goat anti-rabbit IgG (H+L) antibody (A11034, Life Technologies) for 2 h at room temperature. Cells were washed again with PBS and mounted with VECTASHIELD mounting medium with DAPI (H-120, Vector Labs). Images were taken using a Leica DM6000B upright microscope. γH2AX flow cytometry was performed as previously described 33 , with minor modifications. Briefly, after overnight incubation with gentamycin-supplemented medium, cells were lifted using trypsin and harvested. Cells were fixed in ice-cold 2% methanol-free formaldehyde solution (28908, Thermo Scientific Pierce) for 15 min, washed in PBS, and incubated in 70% ethanol overnight at −20°C. Cells were washed with BSA-T-PBS (PBS containing 1% BSA and 0.2% Triton X-100), and incubated with the Alexa Fluor 647 anti-H2A.X-phosphorylated (Ser139) antibody (613407, BioLegend, diluted 1:100 in BSA-T-PBS) overnight at 4°C. Cells were washed with BSA-T-PBS and PI stained. At least 20,000 cells from each sample were analysed using the Accuri C6 flow cytometer (BD Biosciences). Data were further processed using FCS Express 4 software. For estimation of NC101ΔclbM ability to induce γH2AX, a binary system was established by assuming 0% induction in control uninfected cells and 100% in NC101-infected cells, and data from four independent infection/flow cytometry experiments were averaged. Data were analysed using GraphPad Prism 5.0.
Comet assay. Comet assay was performed following the manufacturer's protocol (Trevigen). Briefly, after overnight incubation with gentamycin-supplemented medium, infected cells were collected using trypsin. Cells were mixed with LMAgarose (Trevigen) and spread on 20-well CometSlides (Trevigen). CometSlides were incubated in the lysis buffer (Trevigen) for 1 h at 4°C to lyse cells, and then incubated in alkaline electrophoresis solution (deionized H 2 O containing 200 mM NaOH and 1 mM EDTA) for 20 min at room temperature. Electrophoresis was performed using the CometAssay Electrophoresis System II (Trevigen). DNA was stained with SYBR Gold nucleic acid gel stain (S-11494, Life Technologies) and visualized using the Leica DM6000B upright microscope.
LC-MS detection of N-myristoyl-D-asparagine. E. coli (100 ml) cells, grown overnight to OD 600 = 1, were pelleted by centrifugation. The medium was extracted with ethyl acetate (1:1, vol:vol) using a separatory funnel. The ethyl acetate fraction was removed by rotoevaporation, and dried extracts were redissolved in 3 ml methanol. Pelleted cells were extracted in 2 ml methanol, and combined extracts were run on an Agilent 6130 quadrupole LC-MS with an Agilent Zorbax SB-C18 1.8 μm (2.1 × 50 mm) column. The running method was 0-2 min (H 2 O/0.1% formic acid), 2-22 min (0-100% acetonitrile (ACN)/0.1% formic acid). Compound 1 eluted from the column at 20 min.
E. coli colonization in mice or zebrafish. Germ-free Il10 −/− mice (129/SvEv, 8-12 weeks old, mixed gender) were transferred to a specific-pathogen-free (SPF) room (CGRC 545, University of Florida) and randomly colonized with NC101 (n = 6) or ΔclbM (n = 8) by oral gavage (10 8 per mouse). Ungavaged mice (n = 5) were used as controls. This sample size was based on a previous study showing higher γH2AX in NC101 compared to NC101Δpks-colonized AOM/Il10 −/− mice 6 . Mice were killed 8 days after gavage and stools were collected. Mouse colon tissues were Swiss-rolled and fixed in formalin. Swiss rolls were embedded in paraffin and sectioned by the Molecular Pathology Core at the University of Florida. Stools were homogenized, diluted in sterile PBS, and plated on MacConkey agar plates to enumerate Enterobacteriaceae (blinded). Data were analysed using GraphPad Prism 5.0. The mouse experiment was repeated once.
Zebrafish (AB/Tü wild-type strain) embryos/larvae were treated with 0.015 mg l -1 n-phenylthiourea (PTU) (Sigma) to prevent pigmentation and were unfed for the duration of the experiment. 1 d.p.f. zebrafish were sorted into T25 flasks containing 30 ml autoclaved gnotobiotic zebrafish medium 28 (GZM; dH 2 O, InstantOcean salt and Seachem liquid neutral regulator) at a density of 30 fish per flask. 5 d.p.f. zebrafish were left untreated or colonized with labelled bacteria (E. coli NC101 or ΔclbM transformed with ptdTomato:ampicillin (632531, Takara Clontech)), grown from two overnight cultures, at a density of 6 × 10 7 c.f.u. ml . Intestines were then dissected from each treatment group, homogenized by repeated passage with a 27-gauge insulin syringe, serially diluted and plated onto LB agar and LB agar with ampicillin (100 µg ml ) to determine colonization levels (blinded). A total of 18 fish guts from three independent experiments were analysed for each group. This sample size was selected based on a previous study investigating gut microbe c.f.u. counting and imaging 34 . Data were analysed using GraphPad Prism 5.0.
Examination of γH2AX in vivo. γH2AX in mouse colon Swiss-roll sections was examined by immunohistochemistry (IHC) as described previously 6 . Briefly, γH2AX was detected using the Phospho-Histone H2A.X (Ser139) (20E3) rabbit monoclonal antibody (9718, Cell Signalling), followed Vectastain Elite ABC Rabbit IgG Kit (Vector Labs) for IHC. Images were taken at 500× power using an Olympus CX41 upright microscope. Swiss-roll sections were divided into 13 microscopic fields under ×40 objective on a Leica DM5500B upright microscope. γH2AX positive cells in each field were counted (blinded) and averaged. Data were analysed using GraphPad Prism 5.0.
E. coli imaging in zebrafish. For whole mount immunofluorescence, zebrafish were euthanized and fixed in 4% paraformaldehyde (methanol-free) for 24 h. After fixation, embryos were washed with PBS/Tween 20 and either dehydrated in methanol for storage or immediately stained for 30 min with 1:1,000 diamidino-2-phenylindole (DAPI) solution (Fisher, 1 mg ml -1 ). Fish were incubated in FocusClear (CedarLane) overnight before imaging. Fish were mounted in 1% lowmelting-point agarose on glass-bottomed dishes (MatTek Corporation) and imaged using a Leica TCS-SP5 confocal microscope (×10 objective; z slice size, 1 µm). The z-stack images were reconstructed using Volocity 6.3 software (PerkinElmer).
Drug susceptibility test. E. coli KAM32 35, 36 with acrA and ydhD deleted from the genome, transformed with pK184(clbM), pBACpks or empty vector controls, were used for a chemical susceptibility test. E. coli KAM32 harbouring pMEC2, which expressed efflux pump YdhE, was used as positive control 7 . The MIC was defined as the lowest concentration of a chemical that completely stopped visible growth of the bacteria. Bacteria were pre-cultured overnight at 37°C in LB broth with the appropriate antibiotic. A 50 ml bacterial culture was inoculated into 4 ml LB broth and cultivated for 3 h. The bacterial culture was diluted with LB broth at a concentration of 10 7 c.f.u. ml -1
, and 5 ml diluted culture was added into 100 ml LB broth containing twofold serial diluted chemicals in 96 well plates. The growth of E. coli was examined by visual inspection after 24 h of incubation at 37°C.
Ethidium fluorescence assay. The drug-sensitive strain E. coli C43(DE3)ΔacrAB harbouring the ClbM-pET16b plasmid was grown to OD 600 = 0.6, and ClbM expression was induced with 500 µM isopropyl β-D-thiogalactopyranoside (IPTG) for 2 h at 37°C. Following this, 1 ml aliquots of cells were collected by centrifugation at 50,000g and resuspended in 50 mM Tris-HCl pH 7.5. Cells were incubated with 200 µM ethidium bromide for 1 h. After incubation, the cells were isolated and washed three times with buffer, using centrifugation at 20,000g between washes to isolate the cells. The cells were then resuspended in 3% trifluoroacetic acid to lyse the cells and release the fluorescent content. The cellular debris was removed by centrifugation at 20,000g for 10 min and the fluorescence was measured on a FluoroMax-3 fluorometer (Horiba). The excitation and emission wavelengths were 485 nm and 595 nm, respectively 20 . Transport activity was scaled to the lowest ethidium accumulation inside the cells. Three independent experiments were performed. Data were analysed using GraphPad Prism 5.0.
Cloning, expression and protein purification. The clbM gene was cloned from a bacterial artificial chromosome (BAC) harbouring the colibactin pks island and digested with NcoI/NheI restriction enzymes for ligation into a modified pET16b vector containing a C-terminal deca-histidine tag preceded by an enterokinase cleavage site. Primers used for cloning clbM into expression vectors are as follows: pk184-F, 5′-ATA TGA ATT CGC GGC GCA TTT AAT GAA TAA GG-3′; pk184-R, 5′-GGA ACA GTG CCA CAT CAT TGA TCG GAT CCA TA-3′; pET16b-F, 5′-CTA GTG GCT AGC TGG TGC CAC CTC CAT ATC CAA-3′; pET16b-R, 5′-CTA GTG GCT AGC TGG TGC CAC CTC CAT ATC CAA-3′.
C43(DE3) cells harbouring the clbM-pET16b plasmid were grown to an OD 600 of 0.6 and protein expression was induced with 250 µM IPTG at 20°C for overnight expression. Cells were collected by centrifugation at 8,000g and lysed using a microfluidizer (M-110L Microfluidics). The insoluble material and inclusion bodies were removed by centrifugation at 15,000g for 30 min. Following this, cell membranes were collected by centrifugation at 50,000g for 60 min. Membranes were solubilized in 0.5% n-dodecyl-β-D-maltopyranoside (DDM), 150 mM NaCl, 30% glycerol and 50 mM HEPES-NaOH pH 7.5 for 3 h. Insoluble material was removed by centrifugation at 50,000g for 60 min and the solubilized membranes were incubated with HisPur Ni-NTA resin (Thermo) overnight after the NaCl concentration was brought to 800 mM. After overnight incubation, the resin was washed with 5×10 ml buffer containing 0.05% DDM, 10% glycerol, 25 mM imidazole, 800 mM NaCl and 25 mM HEPES-NaOH pH 7.5. The protein was eluted in the same buffer with 500 mM imidazole. ClbM was immediately purified to homogeneity by size exclusion chromatography (Superdex 200 prep grade HiLoad 16/600, GE Healthcare) in buffer containing 0.05% DDM, 10% glycerol, 150 mM NaCl and 10 mM HEPES pH 7.5.
For a cell localization control, the entS gene was cloned from E. coli BL21(DE3) with an engineered C-terminal deca-His-tag and ligated into the Nhe1/Nco1 sites of pET16b for overexpression. The entS-pET16b plasmid was transformed into E. coli BL21(DE3), which was grown to an OD 600 of 0.6 at 37°C. Expression was initiated by the addition of 80 µM IPTG and growth continued for 4 h at 37°C before the cells were collected by centrifugation. Cell pellets were resuspended in 20 mM TrisHCl pH 7.5 and 0.5 M NaCl. Primers used for cloning entS into expression vectors are as follows: C-EntS-Nhe1 pET16b, 5′-GCG CTC GAG TTA ATG ATG ATG ATG ATG ATG ATG ATG ATG ATG TGC GGC CGC AAG CTT GTC GTC GTC GTC GCT AGC ACT GTC GGA CGC TGT and N-EntS-NcoI pET16b, 5′-GCG CCA TGG ATA AAC AAT CCT GGC.
Inner and outer membrane fractionation and western blot. Inner and outer membranes were separated as described 37 . Briefly, following IPTG induction, E. coli C43(DE3) 38 carrying clbM-pET16b or BL21(DE3) carrying entS-pET16b were lysed using a microfluidizer (M-110L, Microfluidics). Inclusion bodies were removed by centrifugation at 15,000g for 30 min at 4°C. Bacterial membranes were collected by centrifuging the supernatant at 50,000g for 60 min at 4°C. Bacterial membranes were homogenized (Dounce homogenizer) in 2% N-lauroylsarcosine and incubated for 30 min on ice. Outer membranes were separated by centrifuging at 50,000g for 60 min at 4°C. Outer membranes were dissolved in 50 mM Tris-HCl pH 7.5 and 2% SDS. Sample protein concentrations were determined using Bio-Rad Protein Assay Dye Reagent Concentrate (#500-0006, Bio-Rad).
Cellular membrane proteins (5 or 10 μg) were loaded onto 15% SDS polyacrylamide gel electrophoresis (PAGE) gels. The Precision Plus Protein Kaleidoscope Prestained Standard (#161-0375, Bio-Rad) was used as molecular weight standard. One SDS-PAGE gel was stained for 1 h using Coomassie Brilliant Blue G (B0770 Sigma; 0.1% Coomassie Brilliant Blue, 20% methanol and 10% acetic acid in diH 2 O). The gel was destained in 50% methanol, 10% acetic acid in diH 2 O. One gel was used for western blot. Briefly, proteins were transferred to a nitrocellulose membrane (no. 162-0115, Bio-Rad). The membrane was blocked in 5% milk Tris-buffered saline-Tween 20 (TBST) for 1 h and incubated with His·Tag Monoclonal Antibody (no. 70796-3, EMD Millipore; diluted 1:5,000 in 5% milk TBST) at 4°C overnight. The membrane was washed with TBST and incubated with goat anti-mouse IgG-HRP (sc-2005, Santa Cruz Biotechnology; diluted 1:5,000 in TBST) for 1 h at room temperature. The membrane was then washed five times with TBST and incubated with Western Lightning Plus ECL (no. NEL105001EA, PerkinElmer). Blot was performed using blue devil autoradiography film (30-101L, GeneseeScientific).
Crystallization. ClbM purified from size exclusion chromatography was concentrated to 30 mg ml -1 with a 50 kDa molecular weight (MW) centrifugal concentrator (Millipore). Protein was mixed with melted monoolein (Sigma) by hand using the twin-syringe method at a 2/3 protein to lipid ratio (wt/wt). Crystallization trays were prepared manually using a 50× repeating dispenser coupled to a 10 µl syringe. LCP boluses of 200 nl were dispensed onto 96-well glass sandwich plates and overlaid with 1 µl of precipitant solution. Extensive crystal screening was conducted and one initial hit was obtained in 30% PEG 500 DME, 100 mM Li 2 SO 4 , 100 mM NaCl and 100 mM Tris pH 8.0. Optimization of this condition gave crystals that were 20 × 30 µm 2 in size from 30% PEG 500 DME, 100 mM Li 2 SO 4 , 400 mM NaCl and 100 mM sodium cacodylate pH 6.8. Crystals appeared after one day and grew to full size in three days ( Supplementary  Fig. 12A ). For collection, crystals were obtained directly from the sponge phase and flash frozen in liquid nitrogen, using the surrounding sponge phase as a cryoprotectant. Crystals containing rubidium chloride were grown using similar precipitation conditions, but the sodium chloride was replaced with 400 mM rubidium chloride. Crystals grew to 10-20 µm 2 in size and were collected in a similar manner.
Data collection and structure determination. X-ray diffraction data were collected at the Advanced Photon Source GM/CA-CAT beamline 23-ID-D using a beam size of 10 × 10 µm 2 . Approximately 50 crystals were screened for diffraction, with most crystals diffracting to 3.0-3.5 Å. One crystal diffracted to 2.7 Å, and this single crystal was used to solve the apo structure of ClbM (Supplementary Fig. 12B ). The structure of ClbM was determined by molecular replacement using the PfMATE straight conformation as a starting search model in Phaser 39 (Protein Data Bank accession no. 3VVN). The model for ClbM was improved through iterative refinements in Phenix and manual building in Coot 40 , guided by unbiased composite omit maps. The ClbM-Rb structure was solved to 3.3 Å using diffraction data collected from a single crystal using the native ClbM structure as a search model. The structure was verified by a composite omit map.
Accession numbers. ClbM structures have been deposited in the Protein Data Bank under the accession codes 4Z3N for native ClbM and 4Z3P for the Rb + -bound structure.
